We help Support at Home-approved families find care.
Aged Care Home
Support at Home
Retirement Living
Finance & Placement Advice
Healthcare Equipment
Mobility and Equipment
Patient care equipment
Skin and wound Care
Safety and Security
Assessments
Assistive Technology
End of Life
Financial Services
Funerals
Placement Consultants
Advocacy
No results found
No results found
No results found
Advanced Filters
Distance (proximity)
Price Range
RAD (Refundable Accommodation Deposit) is a lump-sum payment for aged care homes. It is fully refundable when the resident leaves, as long as there are no outstanding fees.
Min RAD
Any
$250,000
$500,000
$750,000
$1,000,000
$1,500,000
$1,750,000
$2,000,000
Maximum RAD
Any
$250,000
$500,000
$750,000
$1,000,000
$1,500,000
$1,750,000
$2,000,000
Facility size
Based on how many beds the facilty has.
Any
Small
Medium
Large
Service Delivery
Services offered at a location or in a region
Any
On Site
Service Region
Features
Single rooms with ensuites
Respite beds
Extra service beds
Secure dementia beds
24/7 Registered nursing
Full or Partially government funded
Couples accommodation
Facility has pets
Non-dedicated respite
Palliative care
Partner considered without ACAT
Secure garden
Transition care
Cafe/Kiosk
Chapel/Church
Hairdressing Salon
Facility Owned Transport
Single Rooms
Rooms with ensuites
Registered nursing
Non secure dementia care
Diversional therapy
Medication supervision
Respite care
Secure access
Small pets considered

New water flow to manage cystic fibrosis

Posted
by DPS

A new treatment developed by Australian scientists is showing promise for patients with cystic fibrosis. It involves inhaling a sugar substance called mannitol which brings water into their airways.

Dr Peter Le Soeuf, from Perth’s Princess Margaret Hospital, said it was useful for patients with cystic fibrosis because one of the problems they had was very thick secretion in the airways.
“By bringing water into the airway, that helps lubricate the secretions and helps people cough them up,” he said.

Researchers found the group that received the treatment had a 7% increase in their lung function, while the placebo group had no improvement at all. Despite there being a number of well established treatments for cystic fibrosis such as physiotherapy, even with the current treatments, patients could still suffer lung damage.

The medication has been fast-tracked for approval in the United States but further trials are being held before authorities will consider its approval in Australia.

Read next

Sign up or log in with your phone number
Phone
Enter your phone number to receive a verification notification
Aged Care Guide is endorsed by
COTA logo
ACIA logo